GeoVax Labs (GOVX) had the highest return in February 2000 by a US stock in the Biotechnology Industry, returning 458%.
| ASSET | MONTH | % RETURN |
|---|---|---|
GeoVax Labs (GOVX) | February 2000 | 458.04% |
Regeneron Pharmaceuticals (REGN) | February 2000 | 369.61% |
Alkermes (ALKS) | February 2000 | 189.35% |
Incyte (INCY) | February 2000 | 152.52% |
CASI Pharmaceuticals (CASI) | February 2000 | 148.19% |
GT Biopharma (GTBP) | February 2000 | 145% |
Vericel Corp Ord (VCEL) | February 2000 | 143.38% |
Myriad Genetics (MYGN) | February 2000 | 137.69% |
Armata Pharmaceuticals (ARMP) | February 2000 | 136.86% |
Insmed (INSM) | February 2000 | 128.57% |
Sarepta Therapeutics (SRPT) | February 2000 | 127.32% |
Inovio Pharmaceuticals (INO) | February 2000 | 122.64% |
Soligenix (SNGX) | February 2000 | 120.31% |
Biomarin Pharmaceutical (BMRN) | February 2000 | 117.39% |
Imunon (IMNN) | February 2000 | 111.74% |
Celldex Therapeutics (CLDX) | February 2000 | 98.88% |
Capstone Holding Corp Common Stock (CAPS) | February 2000 | 98.4% |
Anixa Biosciences (ANIX) | February 2000 | 86.84% |
Ionis Pharmaceuticals (IONS) | February 2000 | 85.51% |
CEL-SCI (CVM) | February 2000 | 82.61% |
Vertex Pharmaceuticals (VRTX) | February 2000 | 77.95% |
Geron (GERN) | February 2000 | 76.46% |
TG Therapeutics (TGTX) | February 2000 | 75.26% |
ImmuCell (ICCC) | February 2000 | 66.67% |
Eterna Therapeutics (ERNA) | February 2000 | 65.79% |
